Panel Discussion: Overcoming barriers in drug discovery and development EP News Bureau Oct 1, 2025 Drug discovery, from molecule to patient, is long, risky, and expensive. India has world-class scientific talent and a rapidly…
Aurigene Oncology announces phase 1 results for India’s first CAR-T cell therapy in multiple Myeloma EP News Bureau Oct 9, 2024 SWASTH study reports clinical response in all patients; Drugs Controller General of India approves Phase 2 trial
